275 related articles for article (PubMed ID: 15353417)
21. How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma?
Diamond C; Taylor TH; Im T; Wallace M; Saven A; Anton-Culver H
Cancer Causes Control; 2007 Mar; 18(2):135-42. PubMed ID: 17235495
[TBL] [Abstract][Full Text] [Related]
22. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
23. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
24. Tricyclic antidepressants and non-Hodgkin lymphoma.
Dalton SO; Poulsen AH; Nørgaard M; McLaughlin JK; Johansen C; Friis S
Epidemiology; 2008 Jul; 19(4):546-9. PubMed ID: 18552589
[TBL] [Abstract][Full Text] [Related]
25. High risk occupations for non-Hodgkin's lymphoma in New Zealand: case-control study.
't Mannetje A; Dryson E; Walls C; McLean D; McKenzie F; Maule M; Cheng S; Cunningham C; Kromhout H; Boffetta P; Blair A; Pearce N
Occup Environ Med; 2008 May; 65(5):354-63. PubMed ID: 18032530
[TBL] [Abstract][Full Text] [Related]
26. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
Monnereau A; Orsi L; Troussard X; Berthou C; Fenaux P; Soubeyran P; Marit G; Huguet F; Milpied N; Leporrier M; Hemon D; Clavel J
Cancer Causes Control; 2008 Dec; 19(10):1147-60. PubMed ID: 18781390
[TBL] [Abstract][Full Text] [Related]
27. Tobacco use and non-Hodgkin lymphoma: results from a population-based case-control study in the San Francisco Bay Area, California.
Bracci PM; Holly EA
Cancer Causes Control; 2005 May; 16(4):333-46. PubMed ID: 15953976
[TBL] [Abstract][Full Text] [Related]
28. Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE).
Rudant J; Menegaux F; Leverger G; Baruchel A; Lambilliotte A; Bertrand Y; Patte C; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
Cancer Causes Control; 2008 Dec; 19(10):1277-90. PubMed ID: 18618277
[TBL] [Abstract][Full Text] [Related]
29. Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine.
Rollison DE; Page WF; Crawford H; Gridley G; Wacholder S; Martin J; Miller R; Engels EA
Am J Epidemiol; 2004 Aug; 160(4):317-24. PubMed ID: 15286016
[TBL] [Abstract][Full Text] [Related]
30. Malignant lymphoma in western Ethiopia.
Getachew A
East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
[TBL] [Abstract][Full Text] [Related]
31. Risk of non-Hodgkin's lymphoma and exposure to hexachlorocyclohexane, a nested case-control study.
Rafnsson V
Eur J Cancer; 2006 Nov; 42(16):2781-5. PubMed ID: 16934973
[TBL] [Abstract][Full Text] [Related]
32. Some risk factors for non-Hodgkin's lymphoma.
Persson B; Fredrikson M
Int J Occup Med Environ Health; 1999; 12(2):135-42. PubMed ID: 10465904
[TBL] [Abstract][Full Text] [Related]
33. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphoma--meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories.
Bernatsky S; Lee JL; Rahme E
Rheumatology (Oxford); 2007 Apr; 46(4):690-4. PubMed ID: 17148471
[TBL] [Abstract][Full Text] [Related]
35. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
36. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
37. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
[TBL] [Abstract][Full Text] [Related]
38. Reliability of self-reported family history of cancer in a large case-control study of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Glimelius B; Adami HO
J Natl Cancer Inst; 2006 Jan; 98(1):61-8. PubMed ID: 16391372
[TBL] [Abstract][Full Text] [Related]
39. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes.
Herrinton LJ; Friedman GD
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):25-8. PubMed ID: 9456239
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin's lymphoma in women with breast cancer.
Wiernik PH; Hu X; Ratech H; Fineberg S; Marino P; Schleider MA; Etkind P; Walewski JA
Cancer J; 2000; 6(5):336-42. PubMed ID: 11079174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
